Morpho (MORPHO) is currently trading at $1.89, experiencing a 24-hour decline of 2.50%. The price action has been constrained within a daily range of $1.86 to $1.98, indicating limited volatility despite a relatively high trading volume of approximately $13.89 million, representing 1.32% of the market cap.

The short-term moving averages reflect bearish momentum, with the 8 SMA at $1.89 down 0.22% and the 13 SMA at $1.91 down 1.13%. Further declines are evident in longer moving averages, with the 21 SMA at $1.93 and the 55 and 144 SMAs both at $1.95, showing downtrends of 1.86% and 3.09% respectively, suggesting persistent selling pressure.

The RSI metrics indicate a concerning state of momentum; the 1-hour RSI is at 23, signaling oversold conditions, while the 7-day RSI at 47 implies potential stabilization but lacks clear bullish strength. Additionally, the price has shown a positive change over the last 30 days of approximately 11.24%, indicating a longer-term bullish trend, but the recent short-term performance raises red flags.

Considering the current price is significantly lower than its all-time high of $4.17, there remains substantial upside potential if bullish momentum can be established. However, the ongoing bearish indicators from moving averages and RSI suggest that the immediate market sentiment is cautious.

In summary, while the longer-term outlook for Morpho shows potential for recovery given the previous price increases, the short-term technical indicators are predominantly bearish. Therefore, the recommendation is to Hold MORPHO at this time, as the market appears to be in a consolidation phase that may precede a breakout or further decline depending on upcoming market developments.